Life Scientist > Life Sciences

Scaffold-based method for culturing antitumour bacteria

13 November, 2024

Bacteria-based cancer therapy represents an exciting new treatment option — but in order to fully harness this approach, a safe and efficient method for producing natural anticancer bacteria is needed.


mpox vaccine appears safe and effective in adolescents

12 November, 2024

Interim analysis of an mpox vaccine trial has found the vaccine is safe in adolescents and generates an antibody response equivalent to that seen in adults.


Free meningococcal B vaccines coming to the NT

05 November, 2024

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine program from 1 January 2025 — a commitment that it took to the most recent election.


Germs on travellers' phones present a biosecurity risk

29 October, 2024

Large numbers of microbes are being introduced to Australia via the microbial-contaminated mobile phones of travellers, posing potential threats to local ecosystems, agriculture and public health.


A bout of COVID could protect you from a severe case of flu

25 October, 2024

Recovery from COVID appears to have a protective effect against the worst effects of the flu, with this memory response coming from an unexpected place.


Antibiotic-resistant bacteria exhibit shape differences

24 October, 2024

Researchers have discovered that antibiotic-resistant bacteria exhibit characteristic morphological changes that can be detected microscopically.


Boosting vaccine delivery with bystander immune cells

18 October, 2024

Adding low doses of vaccine-specific antibody to a COVID-19 vaccine stimulates the immune system's B cells, which are responsible for generating antibodies, to fight viral infections.


Low gravity disrupts normal rhythm in heart muscle cells

16 October, 2024

After 48 bioengineered heart tissue samples spent 30 days at the International Space Station, the low-gravity conditions weakened the tissues and disrupted their normal rhythmic beats.


Rejuvenating aged egg cells to improve IVF outcomes

11 October, 2024

Researchers demonstrated the rejuvenation of oocytes from an older preclinical model by using a young follicular environment to partially restore its reproductive function.


Food antigens help to suppress gut tumours

10 October, 2024

Food antigens like milk proteins help keep tumours from growing in the small intestines, with new experiments revealing how these proteins trigger the intestinal immune system.


mpox vaccine candidate reduces disease severity in primates

04 October, 2024

A vaccine candidate from Moderna more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed MVA vaccine.


Shared cellular mechanisms found across three major dementias

02 October, 2024

Researchers have identified degeneration-associated 'molecular markers' that are shared by several forms of dementia, as well as markers specific to different forms of dementia.


More Australians now eligible for free shingles vaccine

01 October, 2024

The free shingles vaccination is now available to more Australians over 18 who are immunocompromised due to an underlying health condition or as a side effect of treatment.


Pioneer bacteria analysed in newborns' microbiomes

19 September, 2024

In the largest known study of UK baby microbiomes to date, researchers have discovered that newborn babies have one of three pioneer bacteria in their gut shortly after birth.


How the aging immune system fuels cancer growth

17 September, 2024

New research reveals how an aging immune system spurs tumour growth, offering new insights into cancer prevention and treatment — especially for older adults.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd